BLK vs DHR: Which Is the Better Buy?
Side-by-side comparison of BlackRock, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
BlackRock, Inc. · Financial Services
$1,050.09
+33.7% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
BLK has more upside to fair value
(+33.7%).
BLK trades at a lower forward P/E
(26.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BLK |
DHR |
| Current Price |
$1,050.09 |
$177.17 |
| Fair Value Estimate |
$1,403.48 |
$192.90 |
| Upside to Fair Value |
+33.7%
|
+8.9%
|
| Market Cap |
$163.0B |
$125.4B |
| Forward P/E |
26.0x
|
34.1x
|
| EV / EBITDA |
16.5x
|
20.8x
|
| Price / Sales |
6.3x
|
5.1x
|
| Price / FCF |
45.7x
|
23.7x
|
| Revenue Growth YoY |
+28.3%
|
+3.7%
|
| Gross Margin |
59.1%
|
60.7%
|
| Operating Margin |
29.9%
|
21.0%
|
| Return on Equity |
11.5%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.19%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
BlackRock, Inc. is a leading global asset manager specializing in investment advisory, ETFs, alternatives, and technology services with a dominant position in institutional indexing and the Aladdin platform. The company benefits from a wide and widening moat supported by strong recurring revenue streams, high margins, and consistent shareholder-friendly capital allocation. Despite a premium valua…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
BLK |
DHR |
| Zone Low |
$1,052.61 |
$144.68 |
| Zone High |
$1,192.96 |
$163.97 |
| In Buy Zone? |
Yes
|
No
|